11 Years and Praise Keeps Coming for ASNC's Nuclear Cardiology Today

“Another fantastic NCToday course! The entire conference was very well organized, and you have perfectly selected the topics (and speakers).” 
“This meeting is definitely one of the best!!”
“Jam packed agenda with relevant topics.”
Attendees at last month's Nuclear Cardiology Today: Best Practices for Today, Innovations for Tomorrow gave the program top marks for usefulness, relevance and overall excellence. In evaluations, they praised the program for taking on today's controversial topics and “answering problems.” Both attendees and faculty remarked on NC Today's interactive approach.

“[T]his meeting hits Technologist and Physician with the best topics,” wrote one attendee. “Great audience participation. Time is available so all questions and concerns can be addressed.” 

More than 90 percent of attendees who completed ASNC's survey rated the overall program as excellent or very good, and almost as many—88 percent—said they are likely to attend next year's course. Participants named “Practical Dilemmas in Nuclear Cardiology: A Case-based Discussion” and The Importance of Quality in Nuclear Cardiology—What is the Technologist Role?” as standout sessions that were particularly relevant to their daily practice.
NC Today Program Directors Dennis A. Calnon, MD, MASNC, and David G. Wolinsky, MD, MASNC, say they love the program every bit as much as attendees. “Well received, educational, enjoyable, and everyone learns,” summarizes Dr. Wolinsky, adding that he and Dr. Calnon “can't wait to start planning 2019.” Stay tuned for details.

View more photos in our NC Today photo album

Thank You
Nuclear Cardiology Today received gold sponsorship from Jubilant DraxImage as well as support from Astellas Pharma US, Inc.; Bracco Diagnostics Inc.; Digirad; IAC; INVIA Medical Imaging Solutions; Ionetix; Medical Outsourcing Solutions; MiE America Inc.; NorthStar Medical Radioisotopes, LLC; Philips Healthcare; Spectrum Dynamics Medical, Inc.; and Triad Isotopes.